PT  - JOURNAL ARTICLE
AU  - SOJIN KIM
AU  - SUNGSIN JO
AU  - HONGKI LEE
AU  - TAE UE KIM
AU  - IL-CHAN KIM
AU  - JOUNG HAN YIM
AU  - HEEKYOUNG CHUNG
TI  - Lobarstin Enhances Chemosensitivity in Human Glioblastoma T98G Cells
DP  - 2013 Dec 01
TA  - Anticancer Research
PG  - 5445--5451
VI  - 33
IP  - 12
4099  - http://ar.iiarjournals.org/content/33/12/5445.short
4100  - http://ar.iiarjournals.org/content/33/12/5445.full
SO  - Anticancer Res2013 Dec 01; 33
AB  - Background/Aim: Lobarstin is a metabolite occurring from the Antarctic lichen Stereocaulon alpnum. Human glioblastoma is highly resistant to chemotherapy with temozolomide. Lobarstin was examined for its effect on glioblastoma. Materials and Methods: Temozolomide-resistant T98G cells were subjected to toxicity test with temozolomide and/or lobarstin. DNA damage and recovery was assessed by the alkaline comet assay and expression of DNA repair genes was examined by RT-PCR and western blot analysis. Results: Lobarstin alone at 40 μM was toxic against T98G, but had no effect in primary human fibroblasts. Co-treatment of lobarstin with temozolomide yielded enhanced toxicity. Temozolomide-alone or with lobarstin co-treatment gave similar extent of DNA damage. However, the recovery was reduced in co-treated cells. Expression of DNA repair genes, O6-methylguanine-DNA methyltransferase, poly(ADP-ribose) polymerase 1 and ligase 3 were reduced in lobarstin-treated cells. Conclusion: Enhanced sensitivity to temozolomide by lobarstin co-treatment may be attributed to reduced DNA repair.